Angiogenesis Inhibitors: all 4,430 studies that test it

Page 12 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.

• Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)CompletedNCT01472081Phase 1Results posted
• Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving BevacizumabCompletedNCT01471691Phase 1/2Results posted
• Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal VasculopathyCompletedNCT01469156Phase 1/2Results posted
• Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by SurgeryActive, not recruitingNCT01468896Phase 1/2Results posted
• Study EvAluating Genotypes While Using Lucentis 2CompletedNCT01464723Phase 4Results posted
• Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide MaintenanceCompletedNCT01463670Phase 2Results posted
• Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or EpendymomaCompletedNCT01462695Phase 2Results posted
• A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedNCT01460940Phase 2Results posted
• Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)CompletedNCT01454102Phase 1Results posted
• Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDSTerminatedNCT01442714Phase 2Results posted
• An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)CompletedNCT01442064Not applicableResults posted
• A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast CancerCompletedNCT01427933Phase 2Results posted
• Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein OcclusionCompletedNCT01427751Phase 4Results posted
• Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell LymphomaActive, not recruitingNCT01415752Phase 2Results posted
• Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMDCompletedNCT01414153Phase 2Results posted
• North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01408030Phase 2Results posted
• Chlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL)TerminatedNCT01403246Phase 1/2Results posted
• Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform NeurofibromasTerminatedNCT01402817Phase 2Results posted
• Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With RanibizumabTerminatedNCT01402544Phase 2/3Results posted
• Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01402531Phase 2Results posted
• Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma PatientsCompletedNCT01402284Phase 2Results posted
• Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaTerminatedNCT01401322Phase 2Results posted
• Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)CompletedNCT01399918Phase 2Results posted
• Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01397695Phase 2Results posted
• A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal TumorCompletedNCT01396148Phase 2Results posted
• Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)CompletedNCT01396083Phase 3Results posted
• Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)CompletedNCT01396057Phase 3Results posted
• Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal FunctionCompletedNCT01393964Phase 1Results posted
• Sunitinib or Cediranib for Alveolar Soft Part SarcomaCompletedNCT01391962Phase 2Results posted
• A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade GliomaCompletedNCT01390948Phase 2Results posted
• Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple MyelomaCompletedNCT01383928Phase 1/2Results posted
• A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal CancerCompletedNCT01383707Phase 2Results posted
• Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple MyelomaCompletedNCT01380106Phase 2Results posted
• A Trial of Lenalidomide & Azacitidine in Low Risk Myelodysplastic SyndromesTerminatedNCT01379274Phase 2Results posted
• Ruxolitinib and Lenalidomide for Patients With MyelofibrosisCompletedNCT01375140Phase 2Results posted
• Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple MyelomaTerminatedNCT01374217Phase 2Results posted
• Oral Lenalidomide and Intravesical BCG for Therapy of Bladder CancerCompletedNCT01373294Phase 2Results posted
• Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)CompletedNCT01373229Phase 1Results posted
• Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular EdemaCompletedNCT01363440Phase 3Results posted
• A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid LeukemiaCompletedNCT01358734Phase 2Results posted
• Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple MyelomaCompletedNCT01355705Phase 1/2Results posted
• Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaActive, not recruitingNCT01351896Phase 2Results posted
• A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)CompletedNCT01351415Phase 3Results posted
• Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma MultiformeCompletedNCT01349660Phase 1/2Results posted
• Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete RemissionCompletedNCT01349569Phase 2Results posted
• Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple MyelomaCompletedNCT01348919Phase 1/2Results posted
• Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never SmokersCompletedNCT01344824Phase 2Results posted
• Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial CarcinomaTerminatedNCT01342172Phase 1/2Results posted
• Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is IndicatedCompletedNCT01332721Phase 1Results posted
• Intravitreal Aflibercept Injection in Vision Impairment Due to DMECompletedNCT01331681Phase 3Results posted
• Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous ChorioretinopathyCompletedNCT01325181Phase 1/2Results posted
• Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple MyelomaCompletedNCT01324947Phase 3Results posted
• A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRITerminatedNCT01322815Phase 2Results posted
• Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal CancerTerminatedNCT01320683Phase 2Results posted
• Continuous Versus Intermittent Dosing Regimens for Pomalidomide in Relapsed/Refractory Multiple MyelomaCompletedNCT01319422Phase 2Results posted
• Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's LymphomaTerminatedNCT01316523Phase 2Results posted
• A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion StudyCompletedNCT01311687Phase 3Results posted
• Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic MelanomaTerminatedNCT01307618Phase 2Results posted
• Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic MalignanciesCompletedNCT01306045Phase 2Results posted
• Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)TerminatedNCT01303965Phase 1/2Results posted
• Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral CavityCompletedNCT01296815Phase 2Results posted
• Carboplatin and Bevacizumab for Recurrent EpendymomaCompletedNCT01295944Phase 2Results posted
• Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein OcclusionCompletedNCT01295112Phase 2/3Results posted
• Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to BevacizumabCompletedNCT01292798Phase 1/2Results posted
• Amgen 386 for Recurrent GlioblastomaCompletedNCT01290263Phase 1/2Results posted
• A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)CompletedNCT01286818Phase 1Results posted
• Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis CarcinomaCompletedNCT01282463Phase 2Results posted
• Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal CancerTerminatedNCT01280643Not applicableResults posted
• A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein OcclusionCompletedNCT01277302Phase 4Results posted
• Lenalidomide in HTLV-1 Adult T-Cell LeukemiaCompletedNCT01274533Phase 2Results posted
• Avastin for PDR (Proliferative Diabetic Retinopathy)CompletedNCT01270542Not applicableResults posted
• BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung CancerCompletedNCT01263782Phase 2Results posted
• Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT01258855Phase 2Results posted
• A Phase 1b Trial in Patients With Renal Cell CancerCompletedNCT01258348Phase 1Results posted
• A Study of Ramucirumab (IMC-1121B) in Participants With Breast CancerCompletedNCT01256567Phase 1Results posted
• Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted TherapiesCompletedNCT01254864Phase 2Results posted
• Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric AdenocarcinomasCompletedNCT01253525Phase 1Results posted
• Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)CompletedNCT01251978Phase 2Results posted
• VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV)CompletedNCT01249664Phase 3Results posted
• A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal CancerCompletedNCT01246960Phase 2Results posted
• Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating AgentsCompletedNCT01246076Phase 2Results posted
• Combination Immunotherapy and Autologous Stem Cell Transplantation for MyelomaCompletedNCT01245673Phase 2Results posted
• Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCTCompletedNCT01242267Phase 1/2Results posted
• Study Examining the Combination of Revlimid (Lenalidomide)and Vidaza (Azacitidine) for Relapsed/Refractory CLL and SLLTerminatedNCT01241786Phase 2Results posted
• Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCLCompletedNCT01241734Phase 1/2Results posted
• A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian CancerCompletedNCT01239732Phase 3Results posted
• Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer PatientsCompletedNCT01234402Phase 2Results posted
• Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by SurgeryCompletedNCT01229943Phase 2Results posted
• A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.CompletedNCT01227707Phase 2Results posted
• Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)TerminatedNCT01225146Phase 1Results posted
• Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory RhabdomyosarcomaCompletedNCT01222715Phase 2Results posted
• Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS)TerminatedNCT01222195Phase 2Results posted
• Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary OvarianCompletedNCT01219777Phase 1Results posted
• Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung CancerStatus unknownNCT01218594Phase 2Results posted
• Study of Everolimus (RAD001) in Combination With LenalidomideCompletedNCT01218555Phase 1Results posted
• A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple MyelomaCompletedNCT01217957Phase 1/2Results posted
• Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal TumorsCompletedNCT01217437Phase 2Results posted
• Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular LymphomaCompletedNCT01216683Phase 2Results posted
• A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic CancerCompletedNCT01214720Phase 3Results posted
• Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT01212952Phase 1/2Results posted

← Angiogenesis Inhibitors overview